These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22123357)

  • 1. Fractional transepidermal delivery: a histological analysis.
    Beltraminelli H; Dietrich N; Hunziker T
    Dermatology; 2011; 223(4):321-4. PubMed ID: 22123357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of histological findings of single session Er:YAG skin fractional resurfacing with various passes and energies and the possible clinical implications.
    Trelles MA; Vélez M; Mordon S
    Lasers Surg Med; 2008 Mar; 40(3):171-7. PubMed ID: 18366083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-engineered skin in the treatment of vitiligo lesions.
    Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
    Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo histological characterization of a novel ablative fractional resurfacing device.
    Hantash BM; Bedi VP; Chan KF; Zachary CB
    Lasers Surg Med; 2007 Feb; 39(2):87-95. PubMed ID: 17115384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo histological evaluation of a novel ablative fractional resurfacing device.
    Hantash BM; Bedi VP; Kapadia B; Rahman Z; Jiang K; Tanner H; Chan KF; Zachary CB
    Lasers Surg Med; 2007 Feb; 39(2):96-107. PubMed ID: 17311274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot clinical study of a novel minimally invasive bipolar microneedle radiofrequency device.
    Hantash BM; Renton B; Berkowitz RL; Stridde BC; Newman J
    Lasers Surg Med; 2009 Feb; 41(2):87-95. PubMed ID: 19226570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
    Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
    J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional versus full ablative CO
    Jamal-Edine AM; El-Barbary RA; Moftah NH
    J Cosmet Dermatol; 2022 Apr; 21(4):1506-1513. PubMed ID: 34213808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
    Gupta S; Goel A; Kanwar AJ; Kumar B
    Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
    Kahn AM; Cohen MJ
    Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs. dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study.
    Silpa-Archa N; Griffith JL; Williams MS; Lim HW; Hamzavi IH
    Br J Dermatol; 2016 Apr; 174(4):895-7. PubMed ID: 26409069
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing melanocyte cultures in a serum-free system for transplantation in vitiligo patients.
    Czajkowski R; Placek W; Drewa T; Olszewska-Słonina D; Sir J; Kowaliszyn B; Weiss M
    Med Sci Monit; 2006 Feb; 12(2):CR63-9. PubMed ID: 16449949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
    Sahni K; Parsad D; Kanwar AJ
    Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo.
    Kaufmann R; Greiner D; Kippenberger S; Bernd A
    Acta Derm Venereol; 1998 Mar; 78(2):136-8. PubMed ID: 9534893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suction blister epidermal grafts combined with CO2 laser superficial ablation as a good method for treating small-sized vitiligo.
    Ko WC; Chen YF
    Dermatol Surg; 2009 Apr; 35(4):601-6. PubMed ID: 19400882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives of surgical treatment of vitiligo].
    Trupar E; Brychta P
    Cas Lek Cesk; 2009; 148(3):129-31. PubMed ID: 19634273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pulse energy variations on the dimensions of microscopic thermal treatment zones in nonablative fractional resurfacing.
    Bedi VP; Chan KF; Sink RK; Hantash BM; Herron GS; Rahman Z; Struck SK; Zachary CB
    Lasers Surg Med; 2007 Feb; 39(2):145-55. PubMed ID: 17096412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.